Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

China flag China · Delayed Price · Currency is CNY
15.47
+0.09 (0.59%)
May 8, 2026, 3:13 PM CST
Market Cap37.03B -31.4%
Revenue (ttm)8.75B -48.5%
Net Income-14.78B
EPS-6.18
Shares Out2.39B
PE Ration/a
Forward PE11.94
Dividendn/a
Ex-Dividend Daten/a
Volume22,903,526
Average Volume16,822,565
Open15.42
Previous Close15.38
Day's Range15.39 - 15.74
52-Week Range14.45 - 26.00
Beta0.59
RSI50.58
Earnings DateApr 28, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysacchar... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 6,292
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300122
Full Company Profile

Financial Performance

Financial Statements